Literature DB >> 16707250

The changing epidemiology of invasive fungal infections: new threats.

Georg Maschmeyer1.   

Abstract

The epidemiology of invasive fungal infections is currently at a crucial stage. Potentially fatal fungal strains are emerging that are resistant to many commonly used antifungal agents. It is therefore important to recognize and minimize the major risk factors associated with infection. This paper summarizes the key epidemiological data.

Entities:  

Mesh：

Year:  2006        PMID： 16707250     DOI： 10.1016/j.ijantimicag.2006.03.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


  11 in total

Review 1.  An insight into the antifungal pipeline: selected new molecules and beyond.

Authors:  Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2010-08-20       Impact factor: 84.694

2.  DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Wolfgang Seifarth; Margit Hummel; Oliver Frank; Alice Fabarius; Chun Zheng; Handan Mörz; Rüdiger Hehlmann; Dieter Buchheidt
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

3.  Extensive chromosome rearrangements distinguish the karyotype of the hypovirulent species Candida dubliniensis from the virulent Candida albicans.

Authors:  B B Magee; Melissa D Sanchez; David Saunders; David Harris; M Berriman; P T Magee
Journal:  Fungal Genet Biol       Date:  2007-07-20       Impact factor: 3.495

4.  Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years.

Authors:  Seon-Sook Han; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Sang-Min Lee
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

Review 5.  Yeasts in the gut: from commensals to infectious agents.

Authors:  Jürgen Schulze; Ulrich Sonnenborn
Journal:  Dtsch Arztebl Int       Date:  2009-12-18       Impact factor: 5.594

Review 6.  The current spectrum of infection in cancer patients with chemotherapy related neutropenia.

Authors:  Lior Nesher; Kenneth V I Rolston
Journal:  Infection       Date:  2013-08-23       Impact factor: 3.553

7.  Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans.

Authors:  Sandeep B Rajput; S Mohan Karuppayil
Journal:  Springerplus       Date:  2013-01-29

8.  Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.

Authors:  Antonella Torosantucci; Paola Chiani; Carla Bromuro; Flavia De Bernardis; Angelina S Palma; Yan Liu; Giuseppina Mignogna; Bruno Maras; Marisa Colone; Annarita Stringaro; Silvia Zamboni; Ten Feizi; Antonio Cassone
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

9.  Computational approaches for discovery of common immunomodulators in fungal infections: towards broad-spectrum immunotherapeutic interventions.

Authors:  Yared H Kidane; Christopher Lawrence; T M Murali
Journal:  BMC Microbiol       Date:  2013-10-07       Impact factor: 3.605

10.  Population-based analysis of invasive fungal infections, France, 2001-2010.

Authors:  Dounia Bitar; Olivier Lortholary; Yann Le Strat; Javier Nicolau; Bruno Coignard; Pierre Tattevin; Didier Che; Françoise Dromer
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.